Ph. Rougier

KRAS status and efficacy in the first-line treatment of patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI with or without cetuximab: The CRYSTAL experience

Sabine Tejpar, István Láng, Gunnar Folprecht, 2008 .